Literature DB >> 15479322

Ultrasound for central venous cannulation: economic evaluation of cost-effectiveness.

N Calvert1, D Hind, R McWilliams, A Davidson, C A Beverley, S M Thomas.   

Abstract

We compared the economics of using two-dimensional ultrasound locating devices and more traditional landmark methods for central venous cannulation in the National Health Service (NHS). The evaluation consisted of a systematic review of randomised controlled trials and an economic evaluation using decision analytic cost-effectiveness modelling. Incremental costs per complication avoided associated with landmark and ultrasound central venous cannulation were modelled for patients scheduled for central venous cannulation. The marginal economic cost of using ultrasound for central venous cannulation was less than 10 pounds sterling per procedure, assuming that a machine is used for 15 procedures each week. The base case scenario implied that 2000 pounds sterling worth of resource savings result for every 1000 procedures undertaken and 90 avoided complications. Sensitivity analysis indicated that the results of modelling appear robust to the central assumptions used. Ultrasound guidance used in central venous cannulation procedures saves NHS resources even with conservative modelling assumptions.

Entities:  

Mesh:

Year:  2004        PMID: 15479322     DOI: 10.1111/j.1365-2044.2004.03906.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  20 in total

1.  Small Ideas for Saving Big Health Care Dollars.

Authors:  Jodi L Liu; Deborah Lai; Jeanne S Ringel; Mary E Vaiana; Jeffrey Wasserman
Journal:  Rand Health Q       Date:  2014-03-01

Review 2.  International evidence-based recommendations on ultrasound-guided vascular access.

Authors:  Massimo Lamperti; Andrew R Bodenham; Mauro Pittiruti; Michael Blaivas; John G Augoustides; Mahmoud Elbarbary; Thierry Pirotte; Dimitrios Karakitsos; Jack Ledonne; Stephanie Doniger; Giancarlo Scoppettuolo; David Feller-Kopman; Wolfram Schummer; Roberto Biffi; Eric Desruennes; Lawrence A Melniker; Susan T Verghese
Journal:  Intensive Care Med       Date:  2012-05-22       Impact factor: 17.440

Review 3.  Ultrasound-guided arterial catheterization: a narrative review.

Authors:  Ariel L Shiloh; Lewis A Eisen
Journal:  Intensive Care Med       Date:  2009-10-31       Impact factor: 17.440

Review 4.  Focus on peripherally inserted central catheters in critically ill patients.

Authors:  Paolo Cotogni; Mauro Pittiruti
Journal:  World J Crit Care Med       Date:  2014-11-04

Review 5.  Totally implantable vascular access devices 30 years after the first procedure. What has changed and what is still unsolved?

Authors:  Roberto Biffi; Adriana Toro; Simonetta Pozzi; Isidoro Di Carlo
Journal:  Support Care Cancer       Date:  2014-06       Impact factor: 3.603

6.  Ultrasound-guided percutaneous insertion of 2.7 Fr tunnelled Broviac lines in neonates and small infants.

Authors:  G S Arul; H Livingstone; P Bromley; J Bennett
Journal:  Pediatr Surg Int       Date:  2010-06-13       Impact factor: 1.827

7.  Cephalic vein cutdown for totally implantable central venous port in children: a retrospective analysis of prospectively collected data.

Authors:  Kyu-Hwan Jung; Suk-Bae Moon
Journal:  Can J Surg       Date:  2014-02       Impact factor: 2.089

8.  Totally Implantable Venous Access Devices in Children Requiring Long-Term Chemotherapy: Analysis of Outcome in 122 Children from a Single Institution.

Authors:  Gowri Shankar; Vinay Jadhav; Narendra Babu
Journal:  Indian J Surg Oncol       Date:  2016-01-13

9.  Obtaining central access in challenging pediatric patients.

Authors:  Cory N Criss; Jake Claflin; Matthew W Ralls; Samir K Gadepalli; Marcus D Jarboe
Journal:  Pediatr Surg Int       Date:  2018-03-26       Impact factor: 1.827

10.  Sonographically guided venous puncture and fluoroscopically guided placement of tunneled, large-bore central venous catheters for bone marrow transplantation-high success rates and low complication rates.

Authors:  Bernhard Gebauer; Ulf Martin Karl Teichgräber; Michael Werk; Alexander Beck; Hans-Joachim Wagner
Journal:  Support Care Cancer       Date:  2008-01-16       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.